HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark C Willingham Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

2/2014Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
9/2003Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark C Willingham Research Topics

Disease

52Neoplasms (Cancer)
01/2020 - 02/2002
15Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 11/2002
9Neoplasm Metastasis (Metastasis)
10/2018 - 09/2003
9Breast Neoplasms (Breast Cancer)
01/2017 - 09/2002
7follicular Thyroid cancer
10/2018 - 05/2007
7Carcinogenesis
01/2016 - 11/2002
7Prostatic Neoplasms (Prostate Cancer)
07/2014 - 01/2003
6Glioblastoma (Glioblastoma Multiforme)
06/2011 - 04/2003
5Glioma (Gliomas)
01/2005 - 04/2003
4Anaplasia
10/2018 - 09/2003
4Hyperplasia
01/2017 - 11/2002
3Pituitary Neoplasms (Pituitary Adenoma)
07/2008 - 09/2003
2Obesity
10/2018 - 01/2017
2Hypothyroidism
05/2014 - 05/2013
2Kidney Neoplasms (Kidney Cancer)
11/2010 - 02/2008
2Follicular Adenocarcinoma
04/2010 - 07/2008
2Atherosclerosis
08/2008 - 10/2004
2Carcinoma (Carcinomatosis)
08/2008 - 09/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2007 - 06/2004
2Malignant Mesothelioma
09/2007 - 04/2004
2Hepatocellular Carcinoma (Hepatoma)
07/2007 - 03/2006
2Lung Neoplasms (Lung Cancer)
03/2007 - 03/2004
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2004 - 01/2004
2Leukemia
05/2004 - 01/2003
2Chronic Kidney Failure (Chronic Renal Failure)
05/2004 - 01/2003
2Brain Neoplasms (Brain Tumor)
10/2003 - 08/2003
2Astrocytoma (Pilocytic Astrocytoma)
10/2003 - 08/2003
1Anaplastic Thyroid Carcinoma
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Weight Loss (Weight Reduction)
07/2014
1Infections
06/2011

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2002
8Messenger RNA (mRNA)IBA
01/2017 - 09/2003
5Cyclin D1IBA
01/2017 - 09/2003
5Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
01/2017 - 02/2014
5RacivirIBA
04/2015 - 05/2007
5Pharmaceutical PreparationsIBA
07/2014 - 10/2003
5Thyroid Hormone Receptors beta (TR beta)IBA
07/2008 - 11/2002
5Immunotoxins (Immunotoxin)IBA
03/2008 - 01/2004
5Diphtheria ToxinIBA
01/2005 - 04/2003
4Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2017 - 11/2002
4Thyroid HormonesIBA
05/2013 - 09/2003
3Caspase 3 (Caspase-3)IBA
10/2018 - 04/2004
3CyclinsIBA
01/2017 - 01/2016
3Retinoblastoma ProteinIBA
01/2017 - 08/2013
3Co-Repressor ProteinsIBA
05/2014 - 01/2013
3MesothelinIBA
09/2007 - 09/2005
3CholesterolIBA
07/2007 - 10/2004
3ErbB Receptors (EGF Receptor)IBA
01/2005 - 08/2003
3Epidermal Growth Factor (EGF)IBA
01/2005 - 04/2003
31,25-dihydroxyvitamin DIBA
06/2004 - 10/2002
2NSC 74859IBA
01/2017 - 01/2016
2Matrix Metalloproteinases (MMPs)IBA
01/2016 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 06/2005
2Protein Isoforms (Isoforms)IBA
05/2015 - 09/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 09/2003
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2013 - 01/2005
2Hormones (Hormone)IBA
01/2013 - 06/2004
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
11/2010 - 02/2008
2IronIBA
08/2010 - 07/2002
2TOR Serine-Threonine KinasesIBA
07/2010 - 12/2007
2PerforinIBA
03/2010 - 10/2006
2Granzymes (Granzyme)IBA
03/2010 - 10/2006
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2008 - 12/2007
2AntigensIBA
06/2008 - 02/2008
2EnzymesIBA
02/2008 - 02/2002
2Calcitriol (Calcijex)FDA LinkGeneric
06/2004 - 05/2004
2paricalcitol (Zemplar)FDA Link
05/2004 - 01/2003
2Parathyroid Hormone (Parathormone)IBA
05/2004 - 01/2003
2Peptides (Polypeptides)IBA
01/2004 - 10/2003
1Steroid Receptors (Steroid Receptor)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2018
1Histones (Histone)IBA
10/2018
1SurvivinIBA
10/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2018
1Metformin (Glucophage)FDA LinkGeneric
10/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2017
1LeptinIBA
01/2017
1VorinostatFDA Link
01/2016
1VimentinIBA
01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1ezrinIBA
01/2016
1Cyclin-Dependent Kinase 4IBA
01/2016
1Biological ProductsIBA
05/2015
1RNA (Ribonucleic Acid)IBA
05/2015
1Testosterone (Sustanon)FDA Link
04/2015
1Gonadal Steroid Hormones (Sex Hormones)IBA
04/2015
1Docetaxel (Taxotere)FDA Link
07/2014
1Fluorouracil (Carac)FDA LinkGeneric
07/2014
1Histone Deacetylase InhibitorsIBA
05/2014
1angiotensin I (1-7)IBA
01/2013
1Hematoxylin (Haematoxylon)IBA
01/2013
1Eosine Yellowish-(YS) (Eosin)IBA
01/2013
1bosutinibIBA
03/2012
1CaspasesIBA
06/2011

Therapy/Procedure

13Therapeutics
10/2018 - 04/2003
3Castration
04/2015 - 05/2010
3Immunotherapy
08/2008 - 02/2007
2Drug Therapy (Chemotherapy)
07/2014 - 10/2003
1Fat-Restricted Diet (Diet, Fat Restricted)
08/2013